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The aim of this study was to investigate whether the accelerated replicative senescence seen in Werner
syndrome (WS) fibroblasts is due to accelerated telomere loss per cell division. Using single telomere length
analysis (STELA) we show that the mean rate of telomere shortening in WS bulk cultures ranges between that
of normal fibroblasts [99 bp/population doubling (PD)] and four times that of normal (355 bp/PD). The
telomere erosion rate in the fastest eroding strain slows in the later stages of culture to that observed in
normal fibroblasts, and appears to be correlated with a reduction in the heterogeneity of the telomere-
length distributions. Telomere erosion rates in clones of WS cells are much reduced compared with bulk cul-
tures, as are the variances of the telomere-length distributions. The overall lack of length heterogeneity and
the normal erosion rates of the clonal populations are consistent with simple end-replication losses as the
major contributor to telomere erosion in WS cells. We propose that telomere dynamics at the single cell
level in WS fibroblasts are not significantly different from those in normal fibroblasts, and suggest that the
accelerated replicative decline seen in WS fibroblasts does not result from accelerated telomere erosion.
INTRODUCTION
Werner syndrome (WS) is an autosomal recessive disease that
displays the premature onset of many age-related phenotypes,
including cataracts, skin atrophy, short stature, premature hair-
greying and symptoms of age-related diseases such as type II
diabetes mellitus, osteoporosis, soft tissue calcification,
premature atherosclerosis and neoplasms of mesenchymal
origin (1–3). With the exception of central nervous system
degeneration, this disease provides a stunning mimicry of
the ageing phenotype and is classified as an adult progeria (4).
At a cellular level, WS fibroblasts in culture display limited
replicative potentials (5) and have a delayed passage through
the S-phase of the cell cycle (6–9). The limited replicative
lifespan correlates with an increased rate of exit from the
cell cycle compared with normal fibroblasts (10). Analyses
of chromosomes from WS cells showed that they have
increased numbers of chromosomal aberrations (11,12),
including deletions (13), and WS has been classified as a
chromosome instability syndrome (14).
The remarkable limitation of replicative potentials of cul-
tured WS fibroblasts has been a major argument in favour of
the Hayflick limit having relevance for ageing in vivo (15).
However, three lines of evidence suggest that the mechanism
of cell cycle exit in WS cells may not be comparable with that
in senescent cells from control subjects. Firstly, in normal
senescent control cultures there is a striking deficiency in
the expression of c-fos on mitogen stimulation, whereas senes-
cent WS cells exhibit a robust c-fos response after such stimu-
lation (16). Secondly, the final telomere lengths in senescent
WS cells appear to be longer than in normal controls, even
though the rate of shortening appears to be accelerated (17).
Telomere shortening is believed to underlie the replicative
senescence of control adult dermal fibroblasts (18,19),
although there are exceptions including some strains of fetal
(20) and mammary (21) fibroblasts. Though it has been
shown that ectopic expression of human telomerase can
immortalize adult dermal fibroblasts from WS individuals
efficiently (22–24), these cells still exhibit slower growth
compared with control cells. Thirdly, the lengthening of cell
cycle parameters (7–9) and the retarded rate of DNA replica-
tion (6) indicate a functional deficit in DNA replication in WS
fibroblasts. This could be a consequence of the reduced ability
of these cells to process stalled replication forks (9), leading to
a proportion of cells with an induced S-phase arrest or delay.
The gene responsible for the WS phenotype encodes a
member of the RecQ helicase family (25), but unlike other
members of the RecQ family WRNp also encodes a 30 to 50
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exonuclease activity (26). WRNp interacts with a range of other
proteins involved in DNA metabolism (27) including proteins
involved in telomere metabolism. WRNp, in conjunction with
the telomere binding protein TRF2 and replication protein A
(RPA), may facilitate the unwinding of long tracts of telomeric
DNA (28). In addition, WRNp can resolve unusual DNA struc-
tures, such as G-tetraplexes, that may occur in the G-rich
telomeric strand (29–31) suggesting that WRNp may poten-
tially play a role in modulating telomere dynamics.
A model suggesting that accelerated senescence in WS
fibroblasts is a direct consequence of an enhanced rate of
telomere loss per cell, resulting in telomere dysfunction, has
been formulated (32). This model is supported by data using
terminal restriction fragment length analysis that appeared to
show an increased rate of telomere erosion in WS cells with
ongoing population doubling (PD), when compared with
normal cells (17). However, because the rates of telomere
erosion for the four WS cultures examined overlapped the
rates of erosion seen in normal cells, no firm conclusions
could be drawn from these results. Additional data using
Epstien–Barr virus-transformed B-lymphoblastoid cells from
WS individuals have shown cases where telomere shortening
has increased, whereas in other cases the telomere erosion
rate has decreased (33). In both of the earlier studies, the
cells appeared to reach replicative arrest with telomeres
longer than those seen in normal cells, although this has not
been confirmed for fibroblasts (23). These data give a rather
confused picture for the role of telomere dynamics in the
reduced replicative capacity of WS cells.
Therefore, in this work we have used high-resolution length
analysis at a single telomere in WS fibroblast strains using a
new method for examining telomere lengths single telomere
length analysis, (STELA) (34), to formally test the hypothesis
that telomere erosion is accelerated in WS cells. Here, we
show that it is possible to obtain WS dermal fibroblasts
that display normal rates of telomere erosion, and suggest
that the accelerated replicative decline seen in WS fibroblasts
does not result from accelerated telomere erosion.
RESULTS
Dynamics of erosion of XpYp telomeres in WS cells
WS fibroblasts were passaged serially in culture until the cells
ceased dividing, as defined as no increase in cell number over
a period of 50 days. Accumulated PDs were monitored with
time. Consistent with previous reports (5,10,12,23), both the
growth rate and the total number of PDs before the onset of
replicative senescence were attenuated considerably when
compared with normal fibroblast cultures (data not shown).
Using STELA, we have described previously the dynamics
of the XpYp telomere during ongoing cell division (CD) in
normal fibroblast and derivative clonal cultures. This revealed
a mean telomere erosion rate of 86+ 42 bp/PD (mean+ SD)
with a range between 20 and 147 bp/PD (34). Analysis of
mean XpYp telomere length using STELA over the life of
the WS cultures revealed substantial telomere erosion with
ongoing CD [mean 219 bp/PD (n ¼ 4), Fig. 1, Table 1], a
telomere erosion rate that is significantly (P , 0.001, two-
tailed z-test) elevated in WS cells compared with normal cells.
However, when the four fibroblast strains were examined
individually a different story emerged.
The fibroblast strain AG03141 showed a loss rate of only
99 bp/PD, a rate that is not significantly different (P . 0.69)
from the mean rate found for telomere loss in normal fibro-
blast strains (Fig. 1, Table 1).
With AG00780 the situation is more complicated. This cell
strain had an average telomere loss rate over the entire life of
the culture of 355 bp/PD (about four times that observed in
normal bulk fibroblast cultures, Fig. 1, Table 1). However,
the vast majority of this loss was accounted for by a loss of
836 bp/PD during the first three PDs of growth (Fig. 1). There-
after, the rate of loss was only 134 bp/PD over a further six
PDs of growth, again not significantly different (P . 0.23)
from the range for normal cell strains.
Plotting the XpYp telomere-length distributions in
AG00780 cells as histograms reveals more detailed infor-
mation on the dynamics of the telomere erosion in this
strain (Fig. 2A). The shape of the distributions changed over
time: for example, at PD8 the variance of the distribution is
.8 kb, which was accounted for by a significant population
(.14%) of cells with telomeres .11 kb in length
Table 1. Mean telomere erosion rates for WS cultures
Cell strain Maximum PD Telomere erosion
rate (bp/PD)a
R 2
AG03141 25.9 99 (P . 0.69) 0.85
AG00780 16.8 355 (P , 0.0001) 0.80
AG12795 14.4 171 (P , 0.045) 0.83
AG05229 15.3 250 (P , 0.0001) 1.00
Mean 219 (P , 0.001)
aThe P-value calculated is the probability that the telomere erosion rates
of WS fibroblasts came from the range of erosion rates of normal fibro-
blast strains [86+ 42 bp/PD (34)].
Figure 1. Mean telomere lengths with ongoing CD at the XpYp telomere for
each of the WS fibroblast strains studied; telomere loss rates are indicated. The
y-axis represents mean XpYp telomere lengths; error bars are +standard
error. The x-axis represents mean PD. The loss rate over the entire lifespan
of the AG00780 culture is 355 bp/PD.
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(Fig. 2A and B). This population of large telomeres was
virtually absent in later passages (,0.5%), and the variance
of the telomere-length distribution had reduced to ,2 kb
(Fig. 2A and B). A possible explanation for this reduction in
heterogeneity is that in the early stages of the culture the
majority of the cells were slow growing and/or growth
arrested. A plausible explanation is that the cells with
telomeres .11 kb represent a clonal lineage that has exhausted
its proliferative capacity, presumably as a consequence of
telomere erosion at telomeres other than XpYp. Thus, the
mean XpYp telomere length in early passages was higher
than the modal length. Dilution of this population brings the
mean length closer to the modal length in later passages
(Fig. 2B). As telomere erosion is determined as a function of
the mean telomere length with PD, the rate of erosion will be
elevated in the earlier passages. However, even taking these
cells into account, the rate of erosion over the first 3 PDs was
still high (504 bp/PD). This may be explained if the majority
of the growth was due to a few replicatively competent cells
that would need to undertake many CDs to achieve 3 PDs for
the culture. Support for this is provided by the observation
that AG00780 cultures at PD8 had a bromodeoxyuridine
(BrdU) labelling index of only 2%, yet this culture achieves 9
PDs of growth, and from the visual inspection of the cultures
where patches of dividing cells could be seen clearly on a back-
ground of non-growing cells data (not shown).
The AG12795 strain showed a telomere loss rate of 171 bp/
PD, which was a little higher than that for normal strains
(P , 0.045, Fig. 1, Table 1). However, as this strain only
achieved 3.4 PD of growth after receipt from the cell repository
before entering replicative senescence (at a final total of
14.4 PD), we were unable to examine the dynamics of telomere
loss in detail. The observation that these cells at PD11 had a
BrdU labelling index of 9% is consistent with telomere loss
rates being generated by a subset of cells in the population.
The apparent telomere erosion rate for the AG05229 strain
was 250 bp/PD, and the culture achieved 8.3 PD of growth.
This was about twice that of the fastest rate of telomere erosion
measured for normal cells (P , 0.0001, Fig. 1, Table 1). Unfor-
tunately, owing to limited cell numbers only two PD points
were obtained for this strain. Thus, the dynamics of telomere
erosion between these points are not known.
Allele-specific telomere loss rates
The WS cell strains AG03141 and AG12795 contain hetero-
zygosities in the DNA adjacent to the XpYp telomere that
allowed separate analysis of single telomeric alleles. The AT
allele has adenine and thymine, at positions 2427 and 2415,
respectively, in the DNA immediately adjacent to the telomere,
whereas the GC allele has guanine and cytosine at these posi-
tions (35). A detailed analysis of the telomere length of the
XpYp alleles in AG03141 at seven PD points revealed a com-
plex pattern of telomere erosion (Fig. 3A). The AT-associated
allele lost telomere repeats with a rate of 139 bp/PD, a rate
that is within the range of telomere erosion rates observed in
normal fibroblast cell cultures (P . 0.19). Unexpectedly, the
GC-associated telomere showed little apparent change in mean
telomere length until the culture reached 21.5 PD; after this
point telomere erosion was resumed (Fig. 3A). However, an
Figure 2. Telomere dynamics of AG00780. (A) XpYp telomere-length distributions of AG00780 plotted as a histogram. Fragment sizes were counted into 1 kb
bins at 100 bp intervals and plotted as a percentage of the total number of molecules. (B) STELA at the XpYp telomere in AG00780 bulk cultures at PD8 and
PD11.1. The mean telomere length and the variance are given below the figure. Each DNA sample is subjected to multiple separate telomere PCR reactions (here
10 reactions are shown for each PD point), each containing up to a maximum of 11 amplifiable telomeric molecules. Different reactions are loaded in separate
lanes. Each visible band is a single telomeric molecule.
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examination of the telomere-length distributions for the GC
allele indicated that the mean length at PD9 was low because
of the presence of a group of small telomeres (Fig. 3B).
The latter have been lost in the subsequent PD points, so the
mean actually showed an initial increase. Because of this
change in the shape of the distribution we used the modal telo-
mere length, which revealed a telomere loss rate of 39 bp/PD
between PD9 and PD21.5, though the subsequent loss appears
more rapid. A slow rate of telomere erosion is also found for
the GC allele in AG12795 cells (41 bp/PD, P . 0.27) com-
pared with the AT allele (158 bp/PD, P . 0.072).
Telomere-length heterogeneity
It is clear from STELA data that normal bulk fibroblast
cultures have broad heterogeneous telomere-length distributions
that become more homogeneous with ongoing CD (34). Single
cell clonal cultures, however, have tight homogeneous
telomere-length distributions. An interpretation consistent
with these data is that the heterogeneity of the telomere-
length profile is related to the number of clonal lineages
present in a culture. In bulk cultures there are a large
number of clonal lineages that reduce with ongoing CD,
with perhaps a single clone dominating the senescent cell
population (34). Thus, in order to help understand the nature
of the growth of WS cultures, we examined the degree of
telomere-length heterogeneity in the WS cultures.
The bulk AG03141 culture could be analysed using allele-
specific STELA, and thus provided the most detailed data on
telomeric heterogeneity. The SDs of the XpYp allele telomere
distributions at the initiation of the culture (PD9) were 1.71
and 1.84 for the AT and GC alleles, respectively. These SDs
were not significantly different from those of single allele
measurements of MRC5 clones (P . 0.10, P . 0.057), but
displayed a significant difference from the SDs of normal
bulk populations (P , 0.021 and P , 0.036, respectively).
Similar results are observed for all seven PD points of this
culture and for both alleles, with an increasingly significant
difference between the AG03141 and the normal bulk popu-
lations with ongoing PD. This is illustrated in Figure 4 by a
comparison of the telomere distributions for the GC allele in
young and senescent MRC5 cells, a clone derived from
MRC5 cells and bulk AG03141 cells. The spread of telomere
lengths in the bulk population of MRC5 cells is much broader
than that seen in the AG03141 cells at a similar telomere
length (see MRC5 at PD29 and AG03141 at PD14.8 and
PD24.9). The reduced rate of increase in the spread of the
AG03141 telomere distributions can readily be explained by
a model whereby AG03141 is composed of a lower number
of clonal lineages than normal bulk fibroblast populations at
all stages of its growth in vitro. In the case of AG03141,
this was coupled with a normal rate of telomere erosion.
The bulk AG00780 culture could not be analysed in an
allele-specific manner, but showed considerable telomere
heterogeneity in the early stages of the culture with an SD
of 2.95, a value not significantly different from bulk normal
cultures (P . 0.55, Fig. 2). However, in the later stages the
SD had reduced to 1.4, a figure distinct from normal bulk
populations but not significantly different from normal
clonal cultures (P . 0.27). Thus, the number of clonal lineages
in AG00780 appeared to be high initially (a point at which
there is a high rate of telomere erosion), and reduced in the
later stages of growth, coincident with a reduction in the
rate of telomere erosion.
Figure 3. Changes in allele-specific XpYp telomere-length distributions for AG03141 with PD. (A) Telomeres linked to the 2427G 2415C haplotype (GC) are
shown as filled squares and those linked to the2427A2415T haplotype (AT) are shown as open squares. A line of best fit is shown for the AT allele but not for
the GC allele (telomere erosion rate for the AT allele indicated). XpYp telomere lengths are given as mean+ standard error. (B, C) STELA of AG03141 GC
alleles at PD9 and PD21.5 and AG03141 GC alleles at PD25.9, respectively.
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Allele-specific analysis of the three PD points available in
AG12795 revealed a reduction in heterogeneity with
ongoing CD, with the SD reducing from 2.53 to 1.57 and
2.74 to 1.91 for the AT and GC alleles, respectively. The
early-stage SDs are not significantly different from normal
bulk fibroblast cultures (P . 0.23 and P . 0.37 for the AT
and GC alleles, respectively), and in the later stages the SD
of the AT allele is not significantly different from normal
clonal cultures (P . 0.16). However, the SD of the GC
allele was slightly higher than normal clonal cultures
(P , 0.045). Thus, for AG12795 a similar picture emerges
as with AG00780, where the culture displayed an apparent
decrease in the number of clonal lineages with ongoing CD.
Only two PD points were available for analysis from
AG05229. These showed a decrease in SD from 3.13 to 2.40,
both of which are not significantly different from normal
bulk fibroblast cultures (P . 0.69 and P . 0.16, respectively).
Thus, although this culture may show a reduction in the
number of clonal lineages with on-going CD, during the
course of its lifespan it did not reach levels significantly differ-
ent from normal cultures. As with the other cultures at a time
when their STELA profiles suggested a high number of clonal
lineages, AG05229 displayed a high telomere erosion rate.
Telomere degradation rates in WS clones
Data generated from bulk cultures are confounded by the
differing replicative histories and kinetics of the cells within
those populations. This can be simplified by clonal analysis,
which allows a more detailed understanding of the dynamics
of telomere erosion (34). We were unable to obtain clones
of WS fibroblasts because these cells grow poorly in highly
diluted cultures; however, it was possible to derive clonal
cultures following retroviral transduction of a vector that
expresses the HPV E6 oncoprotein (36). In these cells, the
abrogation of p53 prevented the onset of M1 senescence,
resulting in an extended replicative lifespan and a faster
growth rate, with the cells entering a second senescence-like
state after some 25 PDs (36,37). All of the E6 clones used
in this study reached this second proliferative arrest (data
not shown). It has been shown that expression of E6 has no
direct effect on telomere dynamics in individual cells
(38,39). We used E6 simply to allow the outgrowth of colonies
with sufficient proliferative potential for at least two points to
be sampled by STELA and thus a telomere loss rate to be
measured.
We used STELA to analyse WS E6 clones derived from all
four WS strains (Table 2). These data revealed tight homo-
geneous telomere-length distributions (Fig. 5), a result that is
typical of that observed in clones from normal fibroblast
strains (Fig. 4B). Crucially, all the E6 clonal cultures for all
four WS strains showed rates of telomere erosion that were
within the range found for normal cell clones (Table 2). This
is particularly apparent when comparing the erosion rates of
the bulk cultures of AG00780, AG05229 and AG12795 (355,
250 and 171 bp/PD, respectively, Table 1) with their E6
Figure 4. STELA profiles of a MRC5 bulk culture, a clone derived from MRC5 cells, and a bulk culture of AG03141 cells. (A) MRC5 GC allele at PD29 and
PD55, (B) MRC5 clone GC alleles at PD48 and PD54, (C) AG03141 GC alleles at PD14.8 and PD24.9. The mean telomere length and the variance are given
below the figure.
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clonal derivatives (102–147, 44 and 30–42 bp/PD, respect-
ively, Table 2). Indeed, the erosion rates for the two
AG00780 clones were the same as that seen in the latter part
of the growth of the bulk population, which provides additional
support for our earlier suggestion that this latter growth is also
clonal in nature. The mean telomere erosion rates of all the
clonal cultures (80+ 40 bp/PD) was essentially the same as
that observed in clones from normal fibroblast strains
(P . 0.84, Table 2). Thus, irrespective of the WS strain used,
these data indicate that it is possible to obtain WS fibroblasts
that do not have accelerated telomere erosion rates.
DISCUSSION
This study set out to test the hypothesis that the accelerated
replicative senescence that is seen in WS fibroblasts is associ-
ated with a fundamental defect in telomere biochemistry and,
in turn, an increased rate of telomere erosion per CD. By the
use of high resolution XpYp telomere length analysis (34),
we examined the dynamics of telomere erosion with ongoing
CD in cultures of four strains of WS fibroblasts. These data
provide information not only on rates of telomere erosion but
also regarding the degree of heterogeneity of the telomere
lengths. Previously, we have shown that the telomere-length
distribution increases in variance as clones of normal fibroblasts
are passaged, an observation in agreement with predictions
from models of telomere erosion based on end-replication
losses. The variance of the telomere-length distribution thus
gives an indirect measure of the number of clonal lineages of
a culture, an important issue when interpreting apparent rates
of telomere erosion in bulk populations of cells (see below).
We studied four independent WS fibroblast strains and analysed
both bulk populations and clonal cultures. To produce the latter,
we were obliged to study cells expressing HPV E6. However,
there are published data that indicate that E6 does not signifi-
cantly affect telomere erosion rates (38,39), a conclusion
supported by our own data (e.g. rates of telomere erosion are
unchanged in both AG03141 cells and E6-expressing
AG03141 cells, Tables 1 and 2). However, we cannot fully
exclude the possibility that E6 expression will affect a
pathway involved in telomere maintenance.
The rate of telomere erosion per PD for bulk WS cultures
varies from a normal rate to a rate around four times that
for normal cells. However, each strain shows a distinctly
different behaviour with respect to the dynamics of telomere
erosion. The AG03141culture has a telomere erosion rate
well within the range seen for clones of normal cells (34).
The AG00780 culture shows a very high rate of telomere
erosion in the first 3 PDs of growth that converts to a
normal rate with ongoing PDs. AG05229 and AG12795
cultures have a high rate of telomere shortening throughout
their lifespan, although the data are more limited for these
two strains. However, for each of the four strains, the telomere
erosion rates in the E6-derived clones are within the range
found for normal cell clones (34). Thus, there are circum-
stances when a normal rate of telomere shortening can be
observed for all four of the WS cell strains.
A consistent picture emerges when comparing the telomere
erosion rates with the variance of the telomere-length distri-
bution. In each case, when normal rates of telomere erosion
are observed in WS cultures, the STELA profile is suggestive
Table 2. Telomere erosion rates for E6-derived WS clones
Clone PD Allele Telomere
length (kb)a
Telomere loss
rate (bp/PD)b
AG03141, E6 clone 2 15.3 AT 3.779+ 0.21 82 (P . 0.92)
21.2 AT 3.289+ 0.12
15.3 GC 5.250+ 0.29 110 (P . 0.55)
21.2 GC 4.597+ 0.26
AG03141, E6 clone 3 14.8 AT 4.119+ 0.48 114 (P . 0.48)
20.1 AT 3.509+ 0.17
14.8 GC 3.758+ 0.60 25 (P . 0.13)
20.1 GC 3.626+ 0.15
AG03141, E6 clone 4 14.5 AT 5.751+ 0.39 101 (P . 0.69)
21.3 AT 5.062+ 0.22
14.5 GC 5.084+ 0.32 80 (P . 0.84)
21.3 GC 4.537+ 0.26
AG12795, E6 clone 3 15.1 AT 4.582+ 0.24 30 (P . 0.16)
16.4 AT 4.543+ 0.30
15.1 GC 5.226+ 0.22 42 (P . 0.27)
16.4 GC 5.171+ 0.20
AG00780, E6 clone 4 19.2 GC 4.500+ 0.18 102 (P . 0.69)
23.6 GC 4.059+ 0.15
AG00780, E6 clone 5 14.5 GC 3.490+ 0.28 147 (P . 0.13)
16.5 GC 3.197+ 0.29
AG05229, E6 clone 6 22.3 AT 3.117+ 0.17 44 (P . 0.27)
23.5 AT 3.064+ 0.18
Mean 80 (P . 0.84)
aThe telomere sizes are given at +95% confidence interval.
bThe P-value calculated is the probability that the telomere erosion rates
of WS fibroblasts came from the range of erosion rates of normal fibro-
blast strains [86+ 42 bp/PD (34)].
Figure 5. STELA profiles of E6-oncoprotein derived WS clones. A single
clone is shown for each of AG00780, AG03141 and AG12795 cells. The
mean telomere length and the variance are given below the figure.
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of a culture that is largely clonal in nature. E6-expressing
clones and WS cultures at a point when they appear naturally
to be clonal show rates of telomere erosion that are not signifi-
cantly different from clones of wild-type fibroblasts. Studying
clones (or clonal cultures) produces the most accurate
estimates of telomere erosion rates per CD, and based on
these data we conclude that the rate of telomere erosion per
CD is unaltered in WS fibroblasts.
Why then do some WS cultures, especially at the beginning
of their lifespan, appear to have unusually high rates of telo-
mere erosion? A possible explanation is that there are con-
founding phenomena in WS, namely, the clonal succession,
attenuation and expansion, that are observed in WS fibroblasts
(11,12,40–42). This phenotype is displayed by normal fibro-
blasts, but to a much lower degree (41,43,44). This clonal
succession may result in the bulk of WS cell growth resulting
from a small number of dividing cells in the population
(40,41). Superimposed upon this clonal succession is a more
rapid exit from the cell cycle (10). These phenomena acting
together lead to an increased rate of change in the mitotic
pool, and as a consequence, telomere loss in the bulk population
measured as a function of PDs will appear higher than in a
normal cell culture, even though the rate of telomere loss per
CD is the same. Thus, a ‘population doubling’ of a bulk WS
culture at an early passage would represent many CDs for the
growing clones, whereas later passages of the population are
dominated by these clones. In this situation, PD estimates
would represent an under-estimate of the actual number of
CDs, and thus telomere erosion rates would appear artificially
high, as they are measured as a function of PDs and not of
CDs. There are several aspects of our data that would be con-
sistent with such a model, especially the reduction in telomere
length variability that uniquely occurs in WS as erosion rates
approach wild-type rates. Our proposed model for the clonal
growth of the WS cultures is shown in Figure 6 (for full
details see legend). In this model, we suggest that the four
WS cultures are at different points in the same process of pro-
ceeding from a culture with a high number to a culture with a
low number of clonal lineages, which possibly reflect their
different replicative histories before explantation.
Our data imply that the accelerated replicative senescence
of WS cells is not mediated by an elevated telomere loss
rate per CD, in contrast to the model suggested earlier (32).
This may appear to contradict previous data reporting an elev-
ated telomere erosion rate in WS cells compared with normal
cells as determined by terminal restriction fragment analysis
which estimates the mean genome-wide telomere length
(17). It should be noted, however, that two of the four WS
strains used previously have telomere erosion rates within
the range found for normal cells; the other two WS strains
had rates approximately twice that for normal cells (17).
These authors concluded that, although telomeres may
shorten faster, this was unlikely to be responsible for the accel-
erated replicative decline seen in WS cells. Our data confirm
and extend these conclusions, and provide strong evidence
that the accelerated replicative decline of a WS culture is
not a result of accelerated telomere erosion due to elevated
end-replication losses at the single cell level.
We therefore postulate that the accelerated replicative
decline seen in WS cells results from a telomere independent
senescence (TIS) mechanism. However, as ectopic expression
of hTERT is known to immortalize WS cells (24), this TIS
mechanism is superimposed upon the normal telomere driven
p53-dependent replicative arrest (36). The two mechanisms,
working in concert, define the maximum possible lifespan of
a WS culture. The actual mechanism of the telomere indepen-
dent arrest is unknown at this time, although it possibly acts
via p53, as it has been shown that abrogation of p53 allows
WS cells to bypass senescence and undergo an extended
lifespan (36).
Our data also inform about some other aspects of the WS
phenotype. The tight distribution of telomere sizes, seen in
both clones and the later stages of the bulk WS cultures,
suggests that telomere erosion itself is unlikely to be any
more heterogeneous than in normal fibroblast strains, despite
the known ‘mutator’ phenotype of WS (13), which a priori
Figure 6. Clonal growth model for WS cultures (adapted from 12,42). Stage A
is a culture where the majority of the cells are slow growing and/or growth
arrested. At stage B, some cells have a growth advantage and expand into
clonal populations (stage C). Most of the cells at late stage C are growth
arrested and a second clonal expanse is seen in stage D. The number of
clonal lineages of the culture is high at stage A and reduces through stages
B to D. The ratio of CDs to PDs is high in early stage B, reduces to parity
by late stage B and in stage C and increases again in stage D. For the WS
strains used, AG03141 would be late in stage B when the culture was first
sampled (PD9) and proceeds to stage C at PD21.5. Therefore the telomere
erosion rate is close to the normal range as the cells are growing exponentially
(CD  PD). For AG00780, the culture is at stage A when initiated and is
proceeding from a state with a high number to a state with a low number of
clonal lineages (stage C). Thus, the apparent rate of telomere erosion is high
initially (CD PD) and then reduces to a normal rate as the culture approaches
stage C (CD  PD). The AG12795 culture would be in the middle of stage
B. AG05229 was possibly at stage A when initiated and approaching stage C
at the end of its growth; however, very little data state this conclusively.
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might have predicted an increased level of deletions or
rearrangements within the telomere that would lead to a
more broadened telomere distribution. Instead, our data are
consistent with telomere erosion in WS cells being predomi-
nantly a consequence of end-replication losses superimposed
with occasional catastrophic telomere deletion similar to that
postulated for normal cells (34,45,46). Although only the
XpYp telomeres are being analysed in this work, there is no
evidence to suggest that the dynamics of the XpYp telomeres
observed in this study are not representative of the dynamics
of other telomeres in the genome; indeed, previous data
demonstrate that it has genetic properties similar to that of
three autosomal telomeres (47,48).
Overall, our data provide little support for the WRN mutation
causing a change in telomere erosion rates as measured per CD;
for all four strains, it was possible to produce cultures that,
despite the absence of the WRNp helicase, showed normal
rates of telomere erosion. Those situations where telomere
erosion rates appeared higher showed additional features indica-
tive of a known feature of WS cultures, namely, a tendency to
grow in a semi-clonal fashion; this in turn distorts measured
telomere erosion rates because the measured PD is no longer
an accurate predictor of the number of CDs undergone. The
significance of these results is that it suggests that future research
into WS should focus on identifying the cause of the slow
growth characteristics of WS cells. To this end, it is provocative
that WRNp has known interactions with proteins involved in
both cell cycle progression, e.g. proliferating cell nuclear
antigen (PCNA) and RPA (28,49,50) and signalling pathways
that can trigger cell cycle arrest or apoptosis, e.g. p53 (51–
53). The interaction between PCNA and WRNp is particularly
interesting because PCNA is a potential communication point
between a variety of important cellular processes, including
cell cycle control, DNA replication, DNA recombination and
repair (54). WS cells are hypersensitive to DNA damaging
agents (e.g. 4-nitroquinoline-1-oxide) and chemicals that
induce inter-strand cross-links such as 8-methoxypsoralen
(55–57). Treatment of WS fibroblasts with these agents leads
to reduced cell proliferation, but not to p53-dependent apoptosis
(57), as the latter is attenuated in WS cells (51). Inter-strand
cross-links may be repaired by homologous recombination
(58), suggesting that WS cells are deficient in resolving the inter-
mediates of homologous recombination and undertaking the
recombinational resolution of stalled replication forks (9). This
deficiency leads to a hyper-recombinant phenotype (59,60) and
a genomic instability observed in WS that results in an increase
in chromosomal aberrations. These data suggest that in WRNp
deficient cells there is a decreased ability to ensure genome
integrity prior to CD, resulting in a proportion of cells with
an induced S-phase arrest or delay. Together, these data
suggest that the reduced rate of growth of WS cultures reflects
a combination of an increased cell cycle transit time (7–9)
and a substantial degree of cell cycle arrest (10).
MATERIALS AND METHODS
Growth of cells
We obtained WS fibroblast cell cultures AG00780, AG03141,
AG05229 and AG12795 from the Coriell cell repository. Of
these AG00780 (R368X) and AG03141 (Q748X) have defined
nonsense mutations in the WRN gene, and AG00780,
AG03141 and AG05229 have no detectable WRNp by
immunoblotting (61,62). Although no WRN mutation has yet
been reported for AG12795, it has all of the major diagnostic
features of WS (Coriell Cell Bank data sheet). Thus, with the
exception of AG12795 we have chosen WS cell lines that do
not express WRNp. Cells were grown in Dulbecco’s modified
Eagle’s medium (Life Technologies) supplemented with 10%
fetal calf serum (Imperial Labs).
DNA synthesis assays
DNA synthesis was assayed by labelling cells in the presence of
10 mM BrdU for 1 h, following which BrdU incorporation was
detected as previously described by immunoperoxidase (63).
Infection of WS cells with HPV E6
WS cells were infected with amphotrophic viruses containing
the E6 oncoprotein essentially as described (36). To obtain E6-
expressing clones with a sufficiently long lifespan for STELA
analysis, the infections were done using WS cells at early
passage, i.e. using the youngest cells available. Clones at
selected PDs were subjected to STELA analysis.
Telomere length analysis
DNA extraction and the determination of XpYp telomere
length by STELA were as previously described (34). Geno-
typing of the 2427 and 2415 XpYp telomere-adjacent
polymorphic sites was as previously described (35).
ACKNOWLEDGEMENTS
We would like to thank members of our laboratories for their
discussions. This work was supported by Research Into
Ageing (RIA) and the BBSRC Experimental Research on
Ageing initiative.
REFERENCES
1. Salk, D. (1982) Werner’s syndrome: a review of recent research with an
analysis of connective tissue metabolism, growth control of cultured cells,
and chromosomal aberrations. Hum. Genet., 62, 1–5.
2. Goto, M., Miller, R.W., Ishikawa, Y. and Sugano, H. (1996) Excess of
rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol.
Biomarkers Prev., 5, 239–246.
3. Martin, G.M., Oshima, J., Gray, M.D. and Poot, M. (1999) What
geriatricians should know about the Werner syndrome. J. Am. Geriatr.
Soc., 47, 1136–1144.
4. Brown, W.T., Kieras, F.J., Houck, G.E., Jr, Dutkowski, R. and Jenkins,
E.C. (1985) A comparison of adult and childhood progerias: Werner
syndrome and Hutchinson–Guildford progeria syndrome. Adv. Exp. Med.
Biol., 190, 229–244.
5. Martin, G.M., Sprague, C.A. and Epstein, C.J. (1970) Replicative
life-span of cultivated human cells. Lab. Invest., 23, 86–92.
6. Fujiwara, Y., Higashikawa, T. and Tatsumi, M. (1977) A retarded rate of
DNA replication and normal level of DNA repair in Werner’s syndrome
fibroblasts in culture. J. Cell. Physiol., 92, 365–374.
7. Takeuchi, F., Hanaoka, F., Goto, M., Yamada, M. and Miyamoto, T.
(1982) Prolongation of S phase and whole cell cycle in Werner’s
syndrome fibroblasts. Exp. Gerontol., 17, 473–480.
1522 Human Molecular Genetics, 2004, Vol. 13, No. 14
8. Poot, M., Hoehn, H., Runger, T.M. and Martin, G.M. (1992) Impaired
S-phase transit of Werner syndrome cells expressed in lymphoblastoid
cells lines. Exp. Cell Res., 202, 267–273.
9. Rodrı´guez-Lo´pez, A.M., Jackson, D.A., Iborra, F. and Cox, L.S. (2002)
Asymmetry of DNA replication fork progression in Werner’s syndrome.
Aging Cell, 1, 30–39.
10. Faragher, R.G.A., Kill, I.R., Hunter, J.A., Pope, F.M., Tannock, C.
and Shall, S. (1993) The gene responsible for Werner syndrome may be
a cell division ‘counting’ gene. Proc. Natl Acad. Sci. USA, 90,
12030–12034.
11. Hoehn, H., Bryant, E.M., Au, K., Norwood, T.H., Boman, H. and Martin,
G.M. (1975) Cytogenetics of Werner’s syndrome cultured skin fibroblasts.
Cytogenet. Cell Genet., 15, 282–298.
12. Salk, D., Au, K., Hoehn, H. and Martin, G.M. (1981) Cytogenetics of
Werner’s syndrome cultured skin fibroblasts: variegated translocation
mosaicism. Cytogenet. Cell Genet., 30, 92–107.
13. Fukuchi, K., Martin, G.M. and Monnat, R.J., Jr (1989) Mutator phenotype
of Werner syndrome is characterised by extensive deletions. Proc. Natl
Acad. Sci. USA, 86, 5893–5897.
14. Meyn, M.S. (1997) In Kastan, M.B. (ed.), Genetic Instability and
Tumorigenesis. Springer, Berlin, pp. 71–148.
15. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human
diploid cell strains. Exp. Cell Res., 25, 585–621.
16. Oshima, J., Campisi, J., Tannock, T.C. and Martin, G.M. (1995)
Regulation of c-fos expression in senescing Werner syndrome fibroblasts
differs from that observed in senescing fibroblasts from normal controls.
J. Cell. Physiol., 162, 277–283.
17. Schulz, V.P., Zakian, V.A., Ogburn, C.E., McKay, J., Jarzebowicz, A.A.,
Edland, S.D. and Martin, G.M. (1996) Accelerated loss of telomere
repeats may not explain accelerated replicative decline in Werner
syndrome cells. Hum. Genet., 97, 750–754.
18. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P.,
Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S. and Wright, W.E.
(1998) Extension of life span by introduction of telomerase into normal
human cells. Science, 279, 349–352.
19. Vaziri, H. and Benchimol, S. (1998) Reconstitution of telomerase activity
in normal human cells leads to elongation of telomeres and extended
reproductive life span. Curr. Biol., 8, 279–282.
20. Forsyth, N.R., Evans, A.P., Shay, J.W. and Wright, W.E. (2003)
Developmental differences in the immortalization of lung fibroblasts by
telomerase. Aging Cell, 2, 235–243.
21. O’Hare, M.J., Bond, J., Clarke, C., Takeuchi, Y., Atherton, A.J., Berry, C.,
Moody, J., Silver, A.R., Davies, D.C., Alsop, A.E. et al. (2001)
Conditional immortalization of freshly isolated human mammary
fibroblasts and endothelial cells. Proc. Natl Acad. Sci. USA, 98, 646–651.
22. Ouellette, M.M., McDaniel, L.D., Wright, W.E., Shay, J.W. and Schultz,
R.A. (2000) The establishment of telomerase-immortalised cell lines
representing human chromosome instability syndromes. Hum. Mol.
Genet., 9, 403–411.
23. Choi, D., Whittier, P.S., Oshima, J. and Funk, W.D. (2001) Telomerase
expression prevents replicative senescence but does not fully reset mRNA
expression patterns in Werner syndrome cell strains. FASEB J., 15,
1014–1020.
24. Wyllie, F.S., Jones, C.J., Skinner, J.W., Haughton, M.F., Wallis, C.,
Wynford-Thomas, D., Faragher, R.G.A. and Kipling, D. (2000)
Telomerase prevents the accelerated ageing of Werner syndrome
fibroblasts. Nat. Genet., 24, 16–17.
25. Yu, C.E., Oshima, J., Fu, Y.H., Wijsman, E.M., Hisama, F., Alisch, R.,
Matthews, S., Nakura, J., Miki, T., Ouais, S. et al. (1996) Positional
cloning of the Werner’s syndrome gene. Science, 272, 258–262.
26. Huang, S., Li, B., Gray, M.D., Oshima, J., Mian, I.S. and Campisi, J.
(1998) The premature ageing syndrome protein, WRN, is a 30 ! 50
exonuclease. Nat. Genet., 20, 114–116.
27. Shen, J.-C. and Loeb, L.A. (2001) Unwinding the molecular basis of the
Werner syndrome. Mech. Ageing Dev., 122, 921–944.
28. Opresko, P.L., von Kobbe, C., Laine, J.P., Harrigan, J., Hickson, I.D. and
Bohr, V.A. (2002) Telomere-binding protein TRF2 binds to and
stimulates the Werner and Bloom syndrome helicases. J. Biol. Chem.,
277, 41110–41119.
29. Fry, M. and Loeb, L.A. (1999) Human Werner syndrome DNA helicase
unwinds tetrahelical structures of the fragile X syndrome repeat sequence
d(CGG)n. J. Biol. Chem., 274, 12797–12802.
30. Kamath-Loeb, A.S., Loeb, L.A., Johansson, E., Burgers, P.M.J. and
Fry, M. (2001) Interactions between the Werner syndrome helicase and
DNA polymerase delta specifically facilitate copying of tetraplex and
hairpin structures of the d(CGG)n trinucleotide repeat sequence. J. Biol.
Chem., 276, 16439–16446.
31. Monaghegh, P., Karow, J.K., Brosh, R.M., Jr, Bohr, V.A. and
Hickson, I.D. (2001) The Bloom’s and Werner’s syndrome proteins are
DNA structure specific helicases. Nucl. Acids Res., 29, 2843–2849.
32. Ostler, E.L., Wallis, C.V., Sheerin, A.N. and Faragher, R.G.A. (2002)
A model for the phenotypic presentation of Werner’s syndrome. Exp.
Gerontol., 37, 285–292.
33. Tahara, H., Tokutake, Y., Maeda, S., Kataoka, H., Watanabe, T.,
Satoh, M., Matsumoto, T., Sugawara, M., Ide, T., Goto, M. et al. (1997)
Abnormal telomere dynamics of B-lymphoblastoid cell strains from
Werner’s syndrome patients transformed by Epstein–Barr virus.
Oncogene, 15, 1911–1920.
34. Baird, D.M., Rowson, J., Wynford-Thomas, D. and Kipling, D. (2003).
Extensive allelic variation and ultrashort telomeres in senescent human
cells. Nat. Genet., 33, 203–207.
35. Baird, D.M., Jeffreys, A.J. and Royle, N.J. (1995) Mechanisms underlying
telomere repeat turnover, revealed by hypervariable variant repeat
distribution patterns in the human Xp/Yp telomere. EMBO J., 14,
5433–5443.
36. Davis, T., Singhrao, S.K., Wyllie, F.S., Haughton, M.F., Smith, P.J.,
Wiltshire, M., Wynford-Thomas, D., Jones, C.J., Faragher, R.G.A. and
Kipling, D. (2003) Telomere-based proliferative lifespan barriers in
Werner-syndrome fibroblasts involve both p53-dependent and p53-
independent mechanisms. J. Cell Sci., 116, 1349–1357.
37. Bond, J.A., Haughton, M.F., Rowson, J.M., Smith, P.J., Gire, V.,
Wynford-Thomas, D. and Wyllie, F.S. (1999) Control of replicative life
span in human cells: barriers to clonal expansion intermediate between
M1 senescence and M2 crisis. Mol. Cell. Biol., 19, 3103–3114.
38. Filatov, L., Golubovskaya, V., Hurt, J.C., Byrd, L.L., Phillips, J.M. and
Kaufmann, W.K. (1998) Chromosomal instability is correlated with
telomere erosion and inactivation of G2 checkpoint function in human
fibroblasts expressing human papillomavirus type 16 E6 oncoprotein.
Oncogene, 16, 1825–1838.
39. Stoppler, H., Hartmann, D.P., Sherman, L. and Schlegel, R. (1997) The
human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular
telomerase activity from the maintenance of telomere length. J. Biol.
Chem., 272, 13 332–13 337.
40. Schonberg, S., Niermeijer, M.F., Bootsma, D., Henderson, E. and German, J.
(1984) Werners syndrome—proliferation in vitro of clones of cells bearing
chromosome translocations. Am. J. Hum. Genet., 36, 387–397.
41. Benn, P.A. (1985) Chromosome translocations in fibroblast-cultures
derived from patients with Werner’s syndrome. Am. J. Hum. Genet., 37,
221–223.
42. Melcher, R., von Golitschek, R., Steinlein, C., Schindler, D., Neitzel, H.,
Kainer, K., Schmid, M. and Hoehn, H. (2000) Spectral karyotyping of
Werner syndrome fibroblast cultures. Cytogenet. Cell Genet., 91,
180–185.
43. Littlefield, L.G. and Mailhes, J.B. (1975) Observations of de novo clones
of cytogenetically aberrant cells in primary fibroblast cell strains from
phenotypically normal women. Am. J. Hum. Genet., 27, 190–197.
44. Benn, P.A. (1977) Population kinetics of chromosomally abnormal
fibroblast sub-populations. Cytogenet. Cell Genet., 19, 137–144.
45. Rubelj, I. and Vondracek, Z. (1999) Stochastic mechanism of cellular
aging-abrupt telomere shortening as a model for stochastic nature of
cellular aging. J. Theor. Biol., 197, 425–438.
46. Tan, Z. (1999) Telomere shortening and the population-size dependency
of the life span of human cell culture: further implication for two
proliferation-restricting telomeres. Exp. Gerontol., 34, 831–842.
47. Baird, D.M., Coleman, J., Rosser, Z.H. and Royle, N.J. (2000) High levels
of sequence polymorphism and linkage disequilibrium at the telomere of
12q: implications for telomere biology and human evolution. Am. J. Hum.
Genet., 66, 235–250.
48. Coleman, J., Baird, D.M. and Royle, N.J. (1999) The plasticity of human
telomeres demonstrated by a hypervariable telomere repeat array that is
located on some copies of 16p and 16q. Hum. Mol. Genet., 8, 1637–1646.
49. Lebel, M., Spillare, E.A., Harris, C.C. and Leder, P. (1999) The Werner
syndrome gene product co-purifies with the DNA replication complex and
interacts with PCNA and topoisomersase I. J. Biol. Chem., 274,
37795–37799.
Human Molecular Genetics, 2004, Vol. 13, No. 14 1523
50. Huang, S., Beresten, S., Li, B., Oshima, J., Ellis, N.A. and Campisi, J.
(2000). Characterization of the human and mouse WRN 30 ! 50
exonuclease. Nucl. Acids Res., 28, 2396–2405.
51. Spillare, E.A., Robles, A.I., Wang, X.W., Shen, J.-C., Yu, C.E.,
Schellenberg, G.D. and Harris, C.C. (1999) p53-mediated
apoptosis is attenuated in Werner syndrome cells. Genes Dev., 13,
1355–1360.
52. Blander, G., Zalle, N., Leal, J.F., Bar-or, R.L., Yu, C.E. and Oren, M.
(2000) The Werner syndrome protein contributes to induction of p53 by
DNA damage. FASEB J., 14, 2138–2140.
53. Brosh, R.M., Jr, Karmakar, P., Sommers, J.A., Yang, Q., Wang, X.W.,
Spillare, E.A., Harris, C.C. and Bohr, V.A. (2001) p53 modulates the
exonuclease activity of Werner syndrome protein. J. Biol. Chem., 276,
35093–35102.
54. Jonsson, Z.O. and Hubscher, U. (1997) Proliferating cell nuclear antigen:
more than a clamp for DNA polymerases. Bioessays, 19, 967–975.
55. Prince, P.R., Ogburn, C.E., Moser, M.J., Emond, M.J., Martin, G.M., and
Monnat, R.J., Jr (1999) Cell fusion corrects the 4-nitroquinoline 1-oxide
sensitivity of Werner syndrome fibroblast cell lines. Hum. Genet., 105,
132–138.
56. Hisama, F.M., Chen, Y.-H., Meyn, M.S., Oshima, J. and Weissman, S.M.
(2000) WRN or telomerase constructs reverse 4-nitroquinoline 1-oxide
sensitivity in transformed Werner Syndrome fibroblasts. Cancer Res., 60,
2372–2376.
57. Poot, M., Gollahon, K.A., Emond, M.J., Silber, J.R. and Rabinovitch, P.S.
(2002) Werner syndrome diploid fibroblasts are sensitive to
4-nitroquinoline-N-oxide and 8-methoxypsoralen: implications for the
disease phenotype. FASEB J., 16, 757–758.
58. Hoeijmakers, J.H. (2001) Genome maintenance mechanisms for
preventing cancer. Nature, 411, 366–374.
59. Cheng, R.Z., Murano, S., Kurz, B. and Shmookler Reis, R.J. (1990)
Homologous recombination is elevated in some Werner-like syndromes
but not during normal in vitro or in vivo senescence of mammalian cells.
Mutat. Res., 237, 259–269.
60. Elli, R., Chessa, L., Antonelli, A., Petrinelli, P., Ambra, R. and
Marcucci, L. (1996) Effects of topoisomerase II inhibition in lymphoblasts
from patients with progeroid and ‘chromosome instability’ syndromes.
Cancer Genet. Cytogenet., 87, 112–116.
61. Marciniak, R.A., Lombard, D.B., Johnson, F.B. and Guarente, L. (1998)
Nucleolar localization of the Werner syndrome protein in human cells.
Proc. Natl Acad. Sci. USA, 95, 6887–6892.
62. Grandori, C., Wu, K.J., Fernandez, P., Ngouenet, C., Grim, J.,
Clurman, B.E., Moser, M.J., Oshima, J., Russell, D.W., Swisshelm, K.
et al. (2003) Werner syndrome protein limits MYC-induced cellular
senescence. Genes Dev., 17, 1569–1574.
63. Bond, J., Haughton, M., Blaydes, J., Gire, V., Wynford-Thomas, D. and
Wyllie, F. (1996) Evidence that transcriptional activation by p53 plays a
direct role in the induction of cellular senescence. Oncogene, 13,
2097–2104.
1524 Human Molecular Genetics, 2004, Vol. 13, No. 14
